Blair William & CO Merck & Co., Inc. Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blair William & CO holds 998,771 shares of MRK stock, worth $101 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

998,771

Previous 738,029 35.33%

Holding current value

$101 Million

Previous $97.4 Million 26.97%

% of portfolio

0.39%

Previous 0.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $32.3 Million - $34.7 Million	260,742 Added 35.33%	998,771 $124 Million
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $35,444 - $41,300	313 Added 0.04%	738,029 $97.4 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $1.51 Million - $1.65 Million	15,121 Added 2.09%	737,716 $80.4 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $441,449 - $490,247	4,288 Added 0.6%	722,595 $74.4 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $1.79 Million - $1.95 Million	16,435 Added 2.34%	718,307 $82.9 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $645,948 - $720,746	6,275 Added 0.9%	701,872 $74.7 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $914,709 - $1.17 Million	10,461 Added 1.53%	695,597 $77.2 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $3.67 Million - $4.12 Million	43,408 Added 6.76%	685,136 $59 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $203,381 - $230,543	2,436 Added 0.38%	641,728 $58.5 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $6.2 Million - $6.96 Million	-84,408 Reduced 11.66%	639,292 $52.5 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.06 Million - $3.84 Million	42,370 Added 6.22%	723,700 $55.5 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $3.94 Million - $4.34 Million	55,013 Added 8.78%	681,330 $51.2 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $703,451 - $778,088	-10,005 Reduced 1.57%	626,317 $48.7 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $2.1 Million - $2.47 Million	-30,458 Reduced 4.57%	636,322 $49.1 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $5.73 Million - $6.35 Million	79,779 Added 13.59%	666,780 $54.5 Million
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $5.68 Million - $6.44 Million	77,638 Added 15.24%	587,001 $48.7 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $1.4 Million - $1.6 Million	19,932 Added 4.07%	509,363 $39.4 Million
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $2.85 Million - $3.94 Million	-44,905 Reduced 8.4%	489,431 $37.7 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $1.31 Million - $1.48 Million	-16,871 Reduced 3.06%	534,336 $48.6 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $2.13 Million - $2.32 Million	27,973 Added 5.35%	551,207 $46.4 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $3.2 Million - $3.73 Million	45,755 Added 9.58%	523,234 $43.9 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $3.63 Million - $4.14 Million	52,106 Added 12.25%	477,479 $39.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $963,138 - $1.12 Million	14,763 Added 3.6%	425,373 $32.5 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $148,782 - $174,959	2,579 Added 0.63%	410,610 $29.1 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $65,875 - $77,397	-1,296 Reduced 0.32%	408,031 $24.8 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $1.09 Million - $1.27 Million	-21,474 Reduced 4.98%	409,327 $22.3 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $61,221 - $73,105	1,186 Added 0.28%	430,801 $24.2 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $25.2 Million - $27.1 Million	429,615	429,615 $27.5 Million

Others Institutions Holding MRK

# of Institutions

3,802

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account